Pediatrics Doctors in Hyde Park, NY Accepting Medicare
3 Pediatrics doctors found. Showing 1 - 3
 Dr. Baldev G Das, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 7 Pine Woods Rd, Hyde Park, NY 12538 Phone: 845-229-8870 Fax: 845-229-8871 |
Dr. Rohidas R. Amin, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 17 Stoutenburgh Dr, Hyde Park, NY 12538 Phone: 845-229-0928 |
 Dr. Rupal Deepak Parikh, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 7 Pine Woods Rd, Hyde Park, NY 12538 Phone: 845-229-8870 Fax: 845-229-8871 |
News Archive
Viewpoints: Rethinking what health insurance should cover; Sen. Johnson suing over congressional health plan; Medicaid's unsung success
The proper role of health insurance should be to finance necessary and expensive medical services without the patient incurring devastating financial consequences. Over the last decade, however, Americans have come to expect their health insurance to subsidize the consumption of all medical care. ... This shift in expectation has meant that health insurance stands out as entirely different from all other types of insurance. Ask yourself: Would you use automobile insurance to buy gasoline? Would you use homeowner insurance to finance painting your house? This wrongheaded view has played an important role in contributing to rapidly rising health care costs (George P. Shultz, Scott W. Atlas and John F. Cogan, 1/5).
Cash gift offered to NTU Singapore to establish new postdoctoral fellowship program
The Knut and Alice Wallenberg Foundation, the largest private financier of research in Sweden, is making a S$9 million cash gift to Nanyang Technological University, Singapore (NTU Singapore) to establish a new postdoctoral fellowship program to support up to 40 fellows over the next six years.
HemoRANK-TKI in vitro assay service package from ReachBio
ReachBio LLC announced today the launch of HemoRANK(TM)-TKI, an in vitro assay service package that helps predict the potential of novel therapeutic tyrosine kinase inhibitors (TKIs) to cause clinical hematotoxicity (myelotoxicity or neutropenia).
Santarus expands development pipeline, adds two novel biologic drug candidates
Santarus, Inc., a specialty biopharmaceutical company, has expanded its development pipeline with the addition of two novel biologic drug candidates focused on specialty markets.
› Verified 4 days ago
Family Medicine
Internal Medicine
Psychiatry & Neurology
Pediatrics
Critical Care Medicine
Rheumatology
Surgery
Allergy & Immunology